Crinetics Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Crinetics Pharmaceuticals, Inc. (CRNX) had Deferred Tax Assets, Operating Loss Carryforwards of $201.11 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $201.11M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $109.14M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $201.11M 10-K · filed 2026-02-26 |
| 2024-12-31 | $109.14M 10-K · filed 2026-02-26 |